Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Grupo Aeroportuario del Pacifico ADR Representing 10 Ord Shs Series B PAC

Industrials Airports & Air Services
Grupo Aeroportuario del Pacifico, S.A.B. de C.V. is a holding company. The Company holds concessions to operate, maintain and develop approximately 10 international airports in the Pacific and Central regions of Mexico, and an international airport in Jamaica. The Company's segments include Guadalajara, Tijuana, Puerto Vallarta, San Jose del Cabo, Montego Bay, Hermosillo, Bajio, Other Airports... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:PAC)

Levi & Korsinsky Reminds Shareholders of an Investigation into PACS Group, Inc. (PAC) Regarding Potential Securities Fraud Allegations

Accesswire 10 days ago

PAC ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your PACS Group, Inc. investment

Accesswire 11 days ago

Levi & Korsinsky Reminds Shareholders of an Investigation into PACS Group, Inc. (PAC) Regarding Potential Securities Fraud Allegations

Accesswire 12 days ago

Investors who Lost Money on PACS Group, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - PAC

Accesswire 13 days ago

Grupo Aeroportuario del Pacifico Announces Payment Date for the Second and Last Installment of the Capital Stock Reduction Approved at the Extraordinary Shareholders' Meeting

GlobeNewswire November 8, 2024

PACS Group, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - PAC

Accesswire November 8, 2024

PACS Group, Inc. (PAC) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

Accesswire November 6, 2024

Grupo Aeroportuario del Pacifico Reports in October 2024 a Passenger Traffic Decrease of 0.8% Compared to 2023

GlobeNewswire November 5, 2024

Grupo Aeroportuario del Pacifico Announces Results for the Third Quarter of 2024

GlobeNewswire October 21, 2024
View More News ››

Opinion & Analysis (NYSE:PAC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:PAC)

PAC Price Target Alert: $210.00. Issued by Bradesco

BREAKING NEWS: $PAC PAC Price Target Alert: $210.00. Issued by Bradesco2024-08-28 08:00:17 ET Rodolfo Ramos from Bradesco issued a price...
whytestocks - August 28, 2024

April 5 Video Break Out Watch List and Audio

This Stalking Stocks commentary video shows several candidates for break out or pullback plays for at least short term gains by buying...
stocktiger_NET - April 4, 2007
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ...
View More »